Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Depomed Inc (NASDAQ:DEPO)

Thursday’s trading has closed, but DEPO is being traded in the after-hours session. After-Hours quote »
16.15
Delayed Data
As of 3:59pm ET
 -0.39 / -2.36%
Today’s Change
12.25
Today|||52-Week Range
33.74
-10.92%
Year-to-Date

Today’s Trading

Previous close16.54
Today’s open16.60
Day’s range16.04 - 16.69
Volume1,928,461
Average volume (3 months)1,929,694
Market cap$1.0B
Dividend yield--
Data as of 3:59pm ET, 05/05/2016

Growth & Valuation

Earnings growth (last year)-161.46%
Earnings growth (this year)+83.22%
Earnings growth (next 5 years)+16.00%
Revenue growth (last year)-12.20%
P/E ratioNM
Price/Sales3.18
Price/Book3.19

Competitors

 Today’s
change
Today’s
% change
BGNEBeiGene Ltd-0.01-0.04%
DNAIProNAi Therapeutics ...-0.29-5.63%
OASMOasmia Pharmaceutica...+0.09+2.16%
NEPTNeptune Technologies...0.000.00%
Data as of 3:59pm ET, 05/05/2016

Financials

Next reporting dateMay 6, 2016
EPS forecast (this quarter)$0.19
Annual revenue (last year)$342.7M
Annual profit (last year)-$75.7M
Net profit margin-22.10%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
James A. Schoeneck
CFO, Senior VP &
Head-Investor Relations
August J. Moretti
Corporate headquarters
Newark, California

Forecasts

Partner Offers

Search for Jobs